Predictors of severe pain in a cohort of 5271 individuals with self-reported neuropathic pain
- PMID: 23140908
- DOI: 10.1016/j.pain.2012.10.001
Predictors of severe pain in a cohort of 5271 individuals with self-reported neuropathic pain
Abstract
The influence of pain descriptors and mechanical hypersensitivity on pain severity in neuropathic pain has not been well researched and is poorly understood. The aim of this study was to determine the relationship between pain severity and other factors describing chronic neuropathic pain in a large cohort of patients with self-reported neuropathic pain potentially recruited as subjects for a Phase IIa study. A questionnaire specific to the study parameters covering demographics and pain characteristics was sent to potential participants. Overall, 9185 questionnaires were returned from potential subjects who self-reported neuropathic pain. Adjusted odds ratios with 95% confidence intervals were used as a measure of association. These were estimated by unconditional logistic regression. Pain descriptors in the questionnaire were: burning, shooting, shocking, and aching. The presence of self-reported allodynia and hyperalgesia was strongly indicative of both moderate and severe pain, with a significant interaction of both factors in moderate and severe pain. Having 3 or 4 pain descriptors was also strongly indicative of both moderate and severe pain. Female gender, age, and history of serious mental disorders were found to be weaker indicators of both moderate and severe pain. Given the large and varied population with many neuropathic pain diagnoses in the study, the findings are not likely to be merely chance, but are likely to reflect important relationships between pain severity and other factors in those who suffer from chronic neuropathic pain.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Similar articles
-
The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population.Eur J Pain. 2017 Apr;21(4):727-737. doi: 10.1002/ejp.977. Epub 2017 Jan 20. Eur J Pain. 2017. PMID: 28107599 Free PMC article.
-
Do We Measure What Patients Feel?: An Analysis of Correspondence Between Somatosensory Modalities Upon Quantitative Sensory Testing and Self-reported Pain Experience.Clin J Pain. 2018 Jul;34(7):610-617. doi: 10.1097/AJP.0000000000000582. Clin J Pain. 2018. PMID: 29271799
-
Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing.Pain. 2019 Sep;160(9):2093-2104. doi: 10.1097/j.pain.0000000000001601. Pain. 2019. PMID: 31162335
-
An overview of predictors for persistent neuropathic pain.Expert Rev Neurother. 2013 May;13(5):505-13. doi: 10.1586/ern.13.44. Expert Rev Neurother. 2013. PMID: 23621308 Review.
-
Sensory descriptors which identify neuropathic pain mechanisms in low back pain: a systematic review.Curr Med Res Opin. 2020 Oct;36(10):1695-1706. doi: 10.1080/03007995.2020.1790349. Epub 2020 Aug 4. Curr Med Res Opin. 2020. PMID: 32609541
Cited by
-
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain.Int J Mol Sci. 2020 Feb 20;21(4):1423. doi: 10.3390/ijms21041423. Int J Mol Sci. 2020. PMID: 32093166 Free PMC article. Review.
-
The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay.J Pediatr Hematol Oncol. 2015 Jan;37(1):10-5. doi: 10.1097/MPH.0000000000000265. J Pediatr Hematol Oncol. 2015. PMID: 25222053 Free PMC article.
-
Risk factors of neuropathic pain after thoracic surgery.J Thorac Dis. 2018 May;10(5):2898-2907. doi: 10.21037/jtd.2018.05.25. J Thorac Dis. 2018. PMID: 29997955 Free PMC article.
-
Significant Quantitative Differences in Orexin Neuronal Activation After Pain Assessments in an Animal Model of Sickle Cell Disease.Front Mol Biosci. 2020 Jan 31;7:5. doi: 10.3389/fmolb.2020.00005. eCollection 2020. Front Mol Biosci. 2020. PMID: 32118032 Free PMC article.
-
Patient and clinician beliefs about potential barriers to treatment of neuropathic pain for adolescents with sickle cell disease.EJHaem. 2023 Dec 1;5(1):11-20. doi: 10.1002/jha2.829. eCollection 2024 Feb. EJHaem. 2023. PMID: 38406507 Free PMC article.
References
-
- Baron R. Neuropathic pain: a clinical perspective. Handb Exp Pharmacol. 2009;194:3-30.
-
- Boogaard S, Heymans MW, Patijn J, de Vet HC, Faber CG, Peters ML, Loer SA, Zuurmond WW, Perez R. Predictors for persistent neuropathic pain – a Delphi survey. Pain Physician. 2011;14:559-568.
-
- Breivik H, Collett B, Ventafridda V, Cohen R, Gallagher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287-333.
-
- Dieleman JP, Kerklaan J, Hujgen FJ, Bouma PA, Sturkenboom MC. Incidence rates and treatment of neuropathic pain conditions in the general population. PAIN®. 2008;137:681-688.
-
- Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL III. Sex, gender, and pain: a review of clinical and experimental findings. J Pain. 2009;10:447-485.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical